Abiopharma

🔍 Raganato Luis Alberto (Executive)

Company: Arcos Dorados Holdings Inc. (ARCO)

Report Date: 2026-05-10

Detailed Transactions and Holdings:

• Acquired 24,239 shares of Class A common share (Direct)
  Date: 2026-05-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 84,273.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 24,239 shares of Class A common share at $9.02 per share (Direct)
  Date: 2026-05-10 | Code: D | equity_swap_involved: 0 | shares_owned_after: 60,034.00 | transaction_form_type: 4
• Sold 24,239 shares of Phantom Restricted Stock Unit (Derivative)
  Date: 2026-05-10 | Code: M | Expires: 2026-05-10 | Exercise: 2026-05-10 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 50,998 shares of Phantom Restricted Stock Unit (Derivative)
  Date: 2026-05-10 | Code: A | Expires: 2029-05-10 | Exercise: 2029-05-10 | equity_swap_involved: 0 | shares_owned_after: 50,998.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Each Phantom Restricted Stock Unit ("Phantom RSU") represents the cash equivalent of the closing price of one Class A common share on the vesting date, plus any dividends paid on the Class A common share, if any, since the grant date.
• F2: On May 10, 2026, the Phantom RSUs vested and were settled in cash automatically pursuant to the issuer's Phantom RSU Award Agreement, without any instruction from the reporting person.
• F3: The Phantom RSUs were issued pursuant to the issuer's Phantom RSU compensation policy, without any instruction from the reporting person.